Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 4 , Pages 303-305 , August 2006

Adolescents and IUCDs—Not a Contraindication

References 

  1. Singh S, Darroch JE. Adolescent pregnancy and childbearing: levels and trends in developed countries. Fam Plann Perspect. 2000;32:14
  2. The Sex Information and Education Council of Canada (SIECCAN): Adolescent sexual and reproductive health in Canada: a report card in 2004. Can J Hum Sex. 2004;13:67
  3. Black A: Intrauterine devices. In: Canadian Contraception Consensus. Edited by A Black, D Francoeur, T Rowe. J Obstet Gynaecol Can 2004; 26:219
  4. ACOG Practice Bulletin No. 59 . Intrauterine device. Obstet Gynecol. 2005;105:223
  5. Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992;339:785
  6. Lee NC, Rubin GL, Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol. 1988;72:1
  7. Grimes DA. Intrauterine device and upper-genital tract infection. Lancet. 2000;356:1013
  8. Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception. 2006;73:145
  9. Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet. 2001;357:443
  10. Faundes A, Telles E, Cristofoletti ML, et al. The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis. Contraception. 1998;58:105
  11. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. 1994;49:56
  12. Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol. 1991;77:261
  13. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 μg/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril. 1994;61:70
  14. Hubacher D, Lara-Ricalde R, Taylor DJ, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001;345:561
  15. Grimes DA. Intrauterine devices and infertility: sifting through the evidence. Lancet. 2001;358:6
  16. Randic L, Haller H. Ectopic pregnancy among past IUD users. Int J Gynecol Obstet. 1992;38:299
  17. Public Health Agency of Canada . 2002 Canadian sexually transmitted infections surveillance report. CCDR. 2005;31S2:1;Available: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05pdf/31s2_e.pdf. Accessed April 12, 2006
  18. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2004. Atlanta, GA: U.S. Department of Health and Human Services, September 2005.
  19. Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception. 1999;60:57
  20. Diaz J, Pinto Neto AM, Bahamondes L, et al. Performance of the copper T 200 in parous adolescents: are copper IUDs suitable for these women?. Contraception. 1993;48:23
  21. Duenas JL, Albert A, Carrasco F. Intrauterine contraception in nulligravid vs. parous women. Contraception. 1996;53:23
  22. Lete I, Morales P, de Pablo JL. Use of intrauterine contraceptive devices in nulliparous women: personal experience over a 12-year period. Eur J Contracept Reprod Health Care. 1998;3:190
  23. Veldhuis HM, Vos AG, Lagro-Janssen ALM. Complications of the intrauterine device in nulliparous and parous women. Eur J Gen Pract. 2004;10:82
  24. Kulig JW, Rauh JL, Burket RL, et al. Experience with the copper 7 intrauterine device in an adolescent population. J Pediatr. 1980;96:746
  25. Weiner E, Berg AA, Johansson I. Copper intrauterine contraceptive devices in adolescent nulliparae. BJOG. 1978;85:204
  26. Trussell J. The essentials of contraception: efficacy, safety, and personal considerations. In:  Hatcher RA,  Trussell J,  Stewart F, et al. editor. Contraceptive Technology, (18th rev ed.). New York: Ardent Media Inc.; 2004;p. 221–252

PII: S1083-3188(06)00166-5

doi: 10.1016/j.jpag.2006.05.014

Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 4 , Pages 303-305 , August 2006

Article Tools